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ABSTRACT 
Aims and objectives: To explore the patientsÕ experience of having malignant melanoma, 
their related support needs and the processes that lead to these needs being met. 
Background: The number of patients attending surveillance clinics after a diagnosis of 
malignant melanoma is increasing. In the UK specialist nurses provide support to patients 
but little evidence exists about the nature of patientsÕ support needs or their experience of 
having melanoma. Melanoma has often been researched within general cancer studies, yet 
the support needs of melanoma patients may be different from those of patients with other 
skin cancers or tumour types. 
Design: A Grounded Theory Approach was used to guide sampling, data collection and 
analysis. 
Methods: In-depth interviews were conducted with eleven patients who where purposively 
sampled. Transcripts were read several times, coded and categorised using the constant 
comparative method. Emergent categories were discussed with participants.  
Results: Three emergent categories related to a core category of melanoma-related worry 
which formed a substantive theory about the strategies patients use to control this. 
Participants reported needing to have their concerns believed by others prior to and after 
diagnosis. They discussed discerning whom to share their concerns with depending upon 
who they felt would not perceive assisting them as being burdensome. They also sought 
ways to reassure themselves.  
Conclusions: Patients need to have their fear and worries acknowledged by others. This 
includes nurses, healthcare professionals and family members. Patients will also use self-
examination and the absence of symptoms to reassure themselves. 
Relevance to clinical practice: Nurses play key roles throughout the patientÕs care; 
therefore they need to be sensitive to the fact that patients may consider them a primary 
source of support. When teaching self-examination it is important that nurses discuss that 
this may ease worry and aid coping. 
!
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SUMMARY BOX  
Patients see melanoma as being different to other cancers, which may result in feelings 
of isolation. 
Patients with melanoma make deliberate choices about sources of support and nurses 
need to be able to recognise when they have been chosen for this role, so that they may 
provide adequate support. 
Self-examination, while a method of surveillance, is also used as a means of 
reassurance that melanoma has not recurred. This should be considered when teaching 
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self-examination to patients. 
 
INTRODUCTION  
Melanoma is a cancer of pigmented cells and the most aggressive skin cancer. Incidence 
has increased in recent years but the number of deaths has remained relatively stable 
(CRUK 2012). This trend has been observed in the UK, Australia and parts of the US, which 
may be due to early diagnosis resulting in curative excision (Bataille & Vries 2008). The 
standard care for patients who are disease free following surgery is considered to be regular 
surveillance (Marsden et al 2010). Some patients experience disease recurrence, undergo 
multiple surgeries and attend clinics for many years. This increasing number of patients is 
placing greater demands on existing services.  
 
Within the United Kingdom, recommendations have been made that each multi-disciplinary 
team should include a Skin Cancer Clinical Nurse Specialist (CNS) whose role is to support 
patients and carers, ensure equality of access to information, identify and respond to the 
needs of patients undergoing disfiguring treatment including psychological support (NICE 
2006a). When developing guidance for the care of people with skin tumours including 
melanoma, the National Institute for Health and Care Excellence (NICE 2006a) found a lack 
of evidence regarding the experience and needs of this patient group. This left nurses with 
the challenge of providing services to meet the needs of melanoma patients with limited 
evidence on which to base care. For nurses to provide evidence based care, it is important 
that there is an understanding about the experience and unique needs of patients with 
melanoma. Where nurses are aware of identified needs relating to specific patients groups, 
care, information provision and support can be tailored to the needs of the individual.  
 
 
BACKGROUND  
A search for literature published after the NICE Guidance (2006a) demonstrated an increase 
in research activity regarding the needs of melanoma patients, but the majority of the 
evidence is generated from self-administrated questionnaires measuring health related 
quality of life (Cornish et al 2009, Cashin et al 2008) rather than exploring the processes 
experienced by patients. General questionnaires might not be sensitive enough for patients 
with early stage melanoma as they do not contain melanoma specific items, such as sun 
avoidance and economic issues, that have been shown to have an impact on this patient 
group (Holterhues et al 2011). Only studies that considered melanoma patients as a discrete 
group following diagnosis were considered as their needs may differ from other cancer 
patients. Patients experience anxiety, distress and sometimes somatic symptoms while 
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waiting for a diagnosis of melanoma, but also a sense of relief on completion of treatment or 
check-ups (Burdon-Jones et al 2010, Cornish et al 2009, Smith 2012,).  
 
A small study found pre-surgery melanoma patients use less effective coping strategies than 
patients requiring surgery for benign skin conditions (Trapp et al 2012). When looking at the 
adjustment of melanoma survivors, cognitive appraisal was found to make a greater 
difference to the adjustment of melanoma survivors than disease related variables such as 
cancer stage at diagnosis or time since diagnosis (Hamama-Raz et al 2007).  Those who 
were more likely to experience negative emotion and less likely to express emotion socially 
were found to have poorer health status than those with other personality types (Mols et al 
2010). Psychosocial factors may therefore be as important in determining patient outcomes 
as the pathological features of the disease and nurses may be best placed to assess these. 
 
Patients with a diagnosis of melanoma have specific information, emotional and 
psychosocial needs, but ways to address these needs are not identified. In studies 
examining the needs of all cancer patients non-melanoma skin cancer as well as melanoma, 
differences were found between the subgroups based on types of cancer  (Al-Shakhli et al 
2006, Burdon-Jones 2010), which indicates patient needs may differ based on the type of 
cancer they have.  This suggests that patients with melanoma may have specific needs, but 
these specific needs are unknown.    
 
Findings from several studies suggest that melanoma patients require comprehensive and 
relevant information that relates to their situation (Constanidou et al 2009,Al-Shakhli et al 
2006, Hertz & Tomasone 2012, Passalacqua et al 2012). These needs are not always met 
(Kasparian 2013). Self-examination of skin and lymph nodes among melanoma survivors is 
not always complete and frequency can vary considerably (Bowen et al 2012, Mujumdar et 
al 2009).The use of support services from psychologists, social workers, oncology nurses, 
physiotherapists, other patients and spiritual care were found to be sporadic (Mols et al 
2010). 
 
It was unclear whether patients require a more comprehensive service, or whether existing 
services are adequate. Although the support needs of patients with melanoma may be met 
by clinical nurse specialists, oncology nurses, community nurses and voluntary services, 
there is a lack of clarity about the type of needs melanoma patients have and what type of 
care is helpful. CNSs have been linked to improved patient outcomes (Department of Health 
2012) but the mechanisms of these improved outcomes are not clear.  Exploration of the 
experience and support needs of patients with melanoma, considering the social process 
involved in their care is therefore required to understand current provision further.  
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STUDY AIM 
To explore the patientsÕ experience of having malignant melanoma, their related support 
needs and the processes that lead to these needs being met. 
 
METHODS  
Design 
To examine the social processes within service provision that make up patient experiences 
and support mechanisms, an inductive approach was considered beneficial, allowing 
participants to freely express their personal experience and identify what was important to 
them. A Grounded Theory approach was therefore chosen as it lends itself to the 
examination of social processes. The original Grounded Theory Methodology described by 
Glazer & Strauss (1967) has been criticised for being objective and could be considered at 
odds with the partnership working currently considered within the National Health Service. A 
constructivist approach to the method suggested by Charmaz (2006) was therefore used to 
allow the participants to guide the study, while using a structured analytic process. Themes 
identified from the literature review were used to guide the study, but these were not 
imposed upon it and those found to be irrelevant were dispensed with (Charmaz 2006).  
 
Participants 
Eleven participants were recruited via melanoma clinics at a specialist cancer centre in 
England seeing approximately 140 new melanoma patients each year. Inclusion and 
exclusion criteria are shown in Table 1. Patients were approached following their routine 
hospital out patient appointment by a member of the medical team and if the patient wished, 
the researcher discussed the study with them. Patients then had the option to make an 
appointment for the interview if they were keen to take part, or to receive a telephone call 
from the researcher a few days later to answer any further questions or arrange the 
interview.  
 
Sampling Procedure 
A theoretical sampling procedure was employed in order to seek pertinent data to develop 
emerging categories and theory (Charmaz 2006). The first three participants were identified 
from all eligible participants attending clinics in the first weeks of recruitment. The data 
collected from these three participants demonstrated some similar experiences and needs 
which warranted further exploration and indicated that the next participants should have 
experienced some recurrent disease. It was anticipated that the length of time since the 
original diagnosis could have an effect on the data so this was taken in to account during 
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subsequent sampling. The emerging categories needed to be tested through the constant 
comparison of new data that may challenge it. The final participants were selected to test 
whether stage in the life cycle influenced the emerging categories. As the new data did not 
conflict with earlier data, or suggest that new factors should be explored, data collection 
ceased when 11 interviews completed and emerging categories appeared to be saturated. 
Demographic details of the 11 participants are shown in Table 2. 
  
Data collection 
Data collection took the format of in-depth interviews. These were audio recorded for 
accuracy and to enable the researcher to focus on the participant. Interviews were carried 
out face-to-face at the participantsÕ choice of setting: their home or the research centre. 
Initial topics to be addressed in the interviews were identified from the literature but this then 
evolved to explore emerging categories.  
 
Questions were phrased to include initial open-ended, intermediate and ending questions 
(Charmaz 2003). Example questions were discussed and tested with a patient 
representative prior to the first interview to ensure issues pertinent to the patients were 
included. The style of questioning was also discussed and how patients could be supported 
if any on-going issues were raised from the interview. Interviews were performed in a 
conversational style with probes being used to encourage the interviewee to share 
information (DiCicco-Bloom & Crabtree 2006). Topics and questions evolved as the 
interviews progressed to reflect the emerging categories. Questions about lifestyle changes 
were added to included self-examination and additional questions about melanoma worry 
were incorporated. 
 
Analysis  
Audio recordings were transcribed and anonymised to maintain confidentiality. Transcripts 
were read several times to gain familiarity with the data. Constant comparative methods 
were used throughout the analytic process with data collection and analysis taking place 
concurrently (Glazer & Strauss 1967). Initial coding was performed line by line to form 
emergent categories from the transcripts. Initial, axial and theoretical coding were then used 
synchronously to link categories and determine their properties (Charmaz 2006). NVivo 8 
was used to assist analysis.  
 
Rigour 
Rigour was addressed by attending to Lincoln & GubaÕs criteria for trustworthiness: 
credibility, transferability, dependability, confirmability (Lincoln & Guba 1985) and 
authenticity (Guba & Lincoln 1994). As a member of the wider clinical team the researcher 
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had experience of the field but was not directly involved in the care of patients recruited to 
the study. A reflective diary was kept in order to record why particular decisions were made, 
aid interpretation and ensure transparency of the process.  Reflecting back on analytic 
decisions enabled the researchers to ensure that data was grounded in patient responses 
rather than researcher generated. Emergent categories from initial interviews were 
discussed with later participants to check meaning and relevance. Interviews were 
transcribed by listening to the recordings several times and correcting errors in transcription. 
During analysis recordings were listened to while reading the transcripts to maintain the 
original meaning of participants. Analysis was conducted by JB but emergent categories and 
selections of the transcripts were also discussed with SD and PC to ensure accuracy of the 
interpretation. As JB & SD worked in the wider clinical area, PC was able to provide a 
differing perspective on the data. 
 
Ethical Considerations 
The research was approved by the regional ethics committee. The principles of the 
Research Governance Framework for Health and Social Care (DH 2005 & 2008) were 
followed and necessary approvals gained.  All patients were given a copy of the Participant 
Information Sheet to take home. Written informed consent was obtained prior to interview. 
This took place at least 24 hours after patients were approached in line with good ethical 
practice. Participants were assured that their participation would remain confidential and 
would not affect their care.  
 
RESULTS 
Three conceptual categories emerged to explain how patients deal with and control 
melanoma-related worry, which formed the core category. This led to a substantive theory 
about strategies to control melanoma-related worry. Patients discussed a need for their 
concerns to be believed (being believed and allowed to worry), how choosing someone to 
share the burden of worry with eased this (sharing the burden) and the strategies they 
employed themselves to reduce their worry and enable them to carry on daily life (doing 
something to help yourself). The categories and their properties are presented below and in 
Table 3.  
 
Melanoma-related worry 
At the time of diagnosis participants spoke about feeling ÔfrightenedÕ, ÔscaredÕ, ÔfearfulÕ, not 
being ÔbraveÕ, being ÔoverwhelmedÕ or feelings of ÔtrepidationÕ. Regardless of whether 
patients experienced recurrence the thought that the melanoma could come back remained. 
In dealing with uncertainty participants contemplated the consequences of recurrence or 
death. They talked about hope and making the most of the time they had as they considered 
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their future and mortality. They looked for reassurance that treatment would be available if 
needed and started to put their affairs in order in case they couldnÕt at a later date. 
 
The anxiety caused by the melanoma diagnosis has a greater magnitude at the beginning of 
treatment and participants talked about worry lessening with time. Participants talked about 
their confidence that the disease was not going to return increasing with time. As such one 
patient stated that self-examination had lessened over time as their confidence had grown. 
 When thinking about the possibility of being discharged from the hospital, patients 
expressed a wish to reduce the number of visits, but did not want them to stop.  
 
 
Being believed and allowed to worry 
Throughout the pathway patients needed to be believed by others including healthcare 
professionals, relatives and friends. They also considered the public perception of what it 
meant to have melanoma. In particular they needed to have their fears or concerns believed 
and understood to be real.  
 
All patients initially sought advice from their General Practitioner (GP) about something that 
was not normal and may have caused them to worry. Where symptoms were not deemed 
problematic, participants stated that they were reassured but this did not make the 
participant feel as though their concerns were warranted or believed. Reassurance was not 
lasting as they sought help again, presenting several times until treatment was offered. 
Patients were persistent in seeking someone (other GPs or nurses) to believe their concerns 
and validate the worry they experienced. The worry related to the presence of symptoms 
was not relieved until they were absent and regular reassurance was not enough. 
 
The need to have someone believe that their concerns were real and justified continued 
throughout the patient experience. The terms melanoma and cancer or skin cancer were 
used almost interchangeably in the interviews, but seen as being different to other cancers. 
The relative rarity compared to other cancers was a part of this. Patients felt that melanoma 
was not seen as being as serious as other cancers so other cancer patients, family and 
friends did not acknowledge their fears. Having their diagnosis played down or not taken 
seriously by other patients, friends or relatives made participantsÕ concerns seem 
unwarranted. The self-perception of not being physically incapacitated contributed to 
melanoma being less serious. The more serious melanoma was perceived to be by 
participants, the greater the concern expressed. Sharing it with family, friends, or healthcare 
professionals relieved this worry or concern.  
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Sharing the burden 
Emotional support was described as having people to talk to and involved family, friends, 
nurses or other health care professionals (HCPs). Talking about it lessened the worry 
associated with a melanoma diagnosis. Being able to talk about feelings was seen as a 
release, a way of dealing with them. When deciding whom to talk to participants chose the 
person that they felt could cope best with the burden of their problems. Participants talked 
about the times where they felt alone as being difficult. 
 
The main source of support for most participants was their partner. Two talked about the 
reciprocal element of support where their partners had also experienced illness, which they 
felt strengthened their relationship. Other participants, however, chose not to talk to family in 
case it added to their burden. This was also the case where participants had adult children 
who they didnÕt want to burden with their problems. Friends also provided this role either in 
addition to family, or where family support wasnÕt either available or appropriate. This was 
particularly the case when wanting to discuss death and partners werenÕt ready to talk about 
the related issues. 
 
Where family and friends were not available or chosen as a source of support, then HCPs 
were used. This was most often the CNS as they could be contacted easily. The need for 
this support continued long after diagnosis and treatment and participants felt able to talk to 
nurses in terms that they understood.  
 
Participants remarked on the importance of being treated as an individual and building a 
relationship with the CNS so that treatment and information could be tailored to their needs.  
The drawback to this familiarity can be a level of dependence. One participant revealed how 
changes in staff after a number of years were difficult to deal with. Where the CNS was not 
selected, it was because the participant felt that they could not take the burden.  
 
The majority of patients had not spoken to other melanoma patients for support. Only one 
participant had spoken to another patient prior to their treatment and found this a positive 
experience as it enabled the burden to be shared with someone who truly understood and 
believed their concerns. One other participant had acted as a source of support for someone 
else diagnosed with melanoma after his own. The participant found that in counselling 
someone else, he also felt better about his own situation, relieving his own worry.  
 
While the main reason for not talking to other patients was found to be not having the 
opportunity to meet them, participants were wary of talking to people who had more disease 
and feeling worse about their own situation. In talking to other patients, there would be the 
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risk of taking on some of the burden of someone elseÕs situation or feeling guilty about 
putting their concerns on to someone that did not have the capacity to take them on. 
 
Two of the participants accessed complementary therapies for counselling and relaxation. 
The main benefit voiced was that they could access someone independent from the hospital 
and without feeling that they were burdening a family member. It is worth noting, however, 
that both participants that accessed complementary therapies were treated some time ago, 
prior to CNS roles and during the interviews they both mused on whether this additional 
support would have changed anything for them.  
 
Doing something to help yourself 
Throughout the patient journey, a need to actively do something to prevent recurrence was 
noted and this offset some worry associated with melanoma. Multiple surgeries including 
skin grafts may be needed. This gave patients a sense that they were doing something 
about it. After surgery though, there was a realisation that this was not the end and that 
treatment, at least in the form of surveillance, would be needed. During follow-up, some 
participants expressed a need to do more to help themselves. Two participants had 
accessed counselling and relaxation services and one had modified their diet. Others 
expressed a need for information on lifestyle changes that could prevent recurrence, but had 
not found any. The lifestyle change common to all patients was that of sun avoidance. All 
participants discussed this in some way, reflecting on past behaviour and additional 
measures now taken to prevent further melanoma. This also extended to their families, as 
they wanted to ensure that family members were also protected from sun exposure.  
 
Reference points were found in order to enable participants to put the melanoma diagnosis 
in to context for themselves. This firstly involved weighing up previous experiences or 
understandings of cancer. Other healthcare priorities, often as experienced by the patient or 
a close family member also aided to construct the patientÕs perspective of how melanoma 
affected them. For one patient a pre-existing condition sometimes took precedent over 
cancer treatment. Two of the participants in the study were pregnant during their diagnosis 
so the safe delivery of their baby was the main concern.  
 
Where another illness affecting a close family member contributed to the construct of the 
patientÕs meaning of melanoma, this was often used to judge the severity of the effect of the 
melanoma. Some patients used previous family events to give context to how difficult they 
were finding the situation. To give the sense that they had been through what they perceived 
to be worse experiences before. These reference points are then used in questioning and 
bargaining processes as the individual makes sense of the diagnosis and how it affects 
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them. While weighing up the gravity of the situation patients considered how bad their 
melanoma was and made comparisons to situations that they considered worse.  
 
Patients who receive a diagnosis of melanoma experience significant worry.  While they try 
to manage this anxiety in many ways, it impacts many aspects of their daily life. Noting the 
absence of symptoms and self-examination were used for this with male participants 
practicing self-examination most often. Where the participant had more confidence in HCPs 
rather than their own self-examination, they found the follow-up essential, especially where 
they had required more than one treatment. Compliance with follow up visits was also 
viewed as a way to help themselves. These caused anxiety beforehand but reassurance 
afterwards for the majority of participants, which gave them permission to not think about 
melanoma until their next hospital visit. 
 
DISCUSSION 
Patients who receive a diagnosis of melanoma experience significant worry which is 
managed in ways that affect many aspects of their daily life. The anxiety caused by potential 
new or recurrent disease persists for years after diagnosis and relates to knowledge that 
metastatic disease is not curable (Mcloone et al 2012). This worry is dealt with by sharing it 
with whomever is felt to be the most appropriate person and engaging in activities to prevent 
recurrence of the disease or give context to their diagnosis.  
 
Where participants had needs that were not met by existing services, they found a way to 
fulfil these needs themselves. This included: finding information, finding an independent 
person to talk to, finding another HCP to talk to and making lifestyle changes. This 
independence should be maintained, but where participants in this study were proactive in 
meeting their own needs, not all patients may be able to do this leaving them with unmet 
needs. 
 
The perception that melanoma is different to other cancers supports the suggestions of 
NICE (2006a), Al-Shakhli et al (2006) and Burdon-Jones et al (2010) that the needs of 
melanoma patients may differ to those with other types of cancer. The findings from this 
study show that preconceptions of melanoma and its severity can affect the patientÕs 
experience. This may relate to a lack of public understanding. The feelings of isolation and 
needing to be believed should to be recognised by nurses and other HCP so that they do not 
inadvertently play down a patients concerns, and instead ensure that they are addressed. 
The view of melanoma not being a serious cancer may be related to disease stage and 
experiences may be different if patients with metastatic melanoma had been interviewed. 
Findings from another study of twenty melanoma survivors found that participants compared 
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their experience to those of people with other cancers and did not consider melanoma to be 
as concerning as treatment had not included chemotherapy (Mcloone et al 2012). 
 
The findings of this study suggest that melanoma patients seek support from a variety of 
sources but choose the one most appropriate to them. This is often their partner. 
Participants most likely to use complementary therapies or CNS for support were those who 
did not have partners or didnÕt want to burden them with their anxieties. Identifying these 
patients to provide support may minimise the distress experienced. If patients see 
themselves as a burden to others then they may need to be given permission to access 
these services. Conversely, where patients are successfully supported by family and friends, 
and do not want additional services, it would not be appropriate to provide this. This 
research only explores the perspective of the patient, whereas their family or carers and 
nurses or other HCPs provide the support network which further work will explore. There is 
also a role for complementary therapies and peer support but the use of these support 
systems needs to be explored further.  
 
The greater need for reassurance at the beginning of follow-up may warrant more flexible 
follow-up patterns. This finding mirrors that of Burgess et al (2005) who found increased 
levels of depression, anxiety, or both in the first year after a diagnosis of early breast cancer 
highlighting the need for dedicated service provision during this time. It could be that 
additional support visits for melanoma patients could be provided by the CNS either in clinics 
or via telephone. It is also appropriate for surveillance visits to be performed by the CNS. 
Patients in our study were able to form a therapeutic relationship with the CNS more than 
other HCPs, which gave them a sense of individualised care. This may contribute to CNS 
involvement being linked to improved patient outcomes (Griffiths et al 2013). 
Multidisciplinary follow up clinics provide a flexible service for this diverse patient group.  
 
Findings relating to the use of self-examination as a method of reassurance differed to those 
found by the report commissioned by NICE (2006b). NICE (2006b) found that patients were 
worried about missing things and only twenty per cent were happy to self-check. In this 
study, however, self-examination was found to be used as a coping mechanism, particularly 
by male participants. Following completion of the research, one other study conducted in 
Australia also found self-examination to be used to provide reassurance that no new disease 
was present (Mcloone et al 2012), suggesting that this finding may be applicable to wider 
clinical settings. Another study of 48 melanoma survivors, however, found that self-
examination of skin and lymph nodes was not always complete and frequency varied 
(Oliveria et al 2013). 
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While used as a coping mechanism for some participants, self-examination is important for 
the detection of recurrent disease. Brecht Francken et al (2007) found that three-quarters of 
first recurrent melanomas were detected by patients or their partners. The authors therefore 
suggest that improved patient education could reduce the frequency of follow up while being 
safe and economical. Evaluation of the effectiveness of educational packages would be 
needed, especially in later years, as one participant spoke of performing less self-
examination as time went on. This would also need to be tempered with some patients not 
having partners to check areas that were difficult to see and the reassurance gained from 
regular surveillance.  
 
Providing evidence based information on ways that patients may do something to help 
themselves may also be beneficial. General lifestyle advice regarding diet, exercise and sun 
protection for the future may be helpful. Melanoma survivors become more aware of the 
need for sun protection, which can cause them to change their lifestyle to limit exposure 
(Oliveria et al 2013, Mcloone et al 2012). 
 
Limitations 
Participants were aware of the study aims prior to interview but the open questioning and 
inductive approach aimed to reduce the possibility of participants saying what they thought 
the researcher wanted to hear. All participants were volunteers and may have had particular 
issues that they wanted to be known that could differ from non-participating patients. There 
may therefore be additional issues that could not be explored by this research method. The 
small homogeneous sample may not be representative of all melanoma patients. 
 
CONCLUSION 
The participants in this study viewed their needs as unique compared to people with other 
cancers. This resulted in them feeling isolated. The uncertainty of the future and possibility 
of disease recurrence can be very difficult to live with. Participants may feel that their 
anxieties are not warranted and need someone to believe them for their worries to be valid.  
 
In order to cope with these feelings, patients choose individuals to share the burden. This 
may be a partner, family, friends, other patients, nurses or other HCPs. Nurses may be 
chosen as the main source of support as frequent contact with the patient allows them to 
build a relationship with the patient. It is therefore important for nurses to recognise when 
they have been selected for this role so that they can meet patientsÕ needs. Sharing the 
burden of melanoma related worry lessens it for the patient.  
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Participants also expressed a desire to help themselves and wanted information on ways to 
prevent recurrence. Self-examination was often used by patients to reassure themselves 
that the melanoma had not recurred.  
 
RELEVANCE TO CLINICAL PRACTICE 
The feelings of isolation caused by a melanoma diagnosis may be related to a lack of public 
awareness of melanoma and how it differs from other types of cancer. This may be related 
to a general lack of awareness of melanoma and should be addressed on a population level. 
The amount of treatment required is not proportionate to the degree of worry experienced by 
patients. Nurses may be best placed to identify this anxiety as they come in to contact with 
patients in a variety of settings throughout the complex pathway of melanoma diagnosis and 
treatment: general practice, outpatients clinics, wards and community.  
 
The patient will choose whomever they feel best able to talk to at that time whether this is a 
specialist nurse or someone independent of their cancer care. It is important that patientÕs 
worries and concerns are listened to and believed in all care settings and for nurses and 
HCPs to recognise their part in the patientÕs support network. They may be part of a large 
network or the main person chosen to share the burden of the patientÕs diagnosis. Holistic 
assessment should include discussion about the patientÕs support network. Identifying a 
need for support that is not met elsewhere may mean that nurses can allocate an 
appropriate amount of time to those patients or suggest additional sources. Peer support 
may reduce feelings of isolation.  
 
This study adds weight to existing evidence that self-examination is used to relieve anxiety.  
Recognising that patients use self-examination as a method of reassurance should be 
considered when teaching this to patients and open discussion about this may aid patient 
counselling.  
 
WORD COUNT 4941 
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Table 1: Participant inclusion & exclusion criteria 
Inclusion 
Over 18 years of age 
Able to understand what the study involves and give informed consent 
Histological diagnosis of melanoma 
No clinical evidence of metastatic disease in situ  
May have had one or more surgical procedure for melanoma 
Must be attending clinics for regular surveillance 
 
Exclusion 
Under 18 years of age 
Not able to give informed consent 
Recurrent or metastatic disease in situ at recruitment 
Requiring treatment for melanoma at recruitment 
 
Table 2: Participant demographics 
Participant 
ID 
Gender Age Time 
from 
diagnosis 
Stage at 
diagnosis 
Stage at 
recruitment 
Number 
of 
surgeries 
Other 
treatments 
P01 F 61 1 year IIC IIC 3  
P02 F 31 1 year IIB IIB 3  
P03 F 68 1 year IIIB IIIB 2  
P04 M 77 4 years IIC IIC 2  
P05 M 42 8 years IIC IV 6 Radiotherapy 
P06 M 63 5 years II* II* 2  
P07 M 67 1 year IIIB IIIB 5  
P08 F 71 11 years IIIB IV 7 Interleukin & 
Interferon 
P09 F 83 5 years IIC IIIB 2  
P10 F 36 7 years IIC IIIB 3  
P11 M 70 3 years IIC IIIB 6  
* Further staging not available as removed by curettage. 
 
 
Table 3: Emergent categories and their properties 
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Category Property Dimension  
Melanoma 
related 
worry 
Feeling 
Isolated 
 
 
 
 
 
 
 
 
 
 
 
 
Uncertainty of 
future 
recurrence 
 
Worry not being 
understood by 
family and friends 
  
 
 
 
 
 
 
 
 
 
 
Not knowing if it 
will come back 
 
Wondering if 
there will be 
treatment if it 
does come back 
 
Thinking about 
mortality 
 
ÒIt was a bit frightening sort of being out 
there and of course everybody else in 
the hospital, you know with lumps in 
their breast, lumps in bowels and IÕm 
sort of saying melanoma. And they all 
seemed to say oh is that all it was, you 
know, and yet mine was probably more 
dangerous….Ó Participant 08 
 
Ò…it was a bit isolating I think because 
itÕs not your usual cancer… It was hard. I 
just felt as if I were a bit out on a limb.Ó 
Participant 09 
 
ÒI would be worried if I wouldnÕt be 
checked regularly…even now, they 
discover. Well not every time a mole 
which started behaving badly.Ó 
Participant 05 
 
Ò…then it meant the 40% chance of you 
know it spreading further.... But touch 
wood so far weÕre staying on the 60% 
side.Ó Participant 10 
 
 
Being 
believed and 
allowed to 
worry 
Not being 
believed 
Repeatedly 
asking for help for 
persistent 
problem 
 
Not being ill or 
sick 
 
 
 
Melanoma is 
cancer 
ÒSo every six months I said while youÕre 
at it just have a look. And it was always 
looked at, no itÕs alright, no problem.Ó 
Participant 11 
 
ÒIÕve never been ill with it. Never had a 
day off work with it. So itÕs not, it hasnÕt 
been an illness in that respect.Ó 
Participant 06 
 
ÒYouÕre in a lot of trouble, youÕve got 
cancer … ItÕs like a death sentence isnÕt 
! 20 
It is serious 
 
it until you actually get things sorted out.Ó 
Participant 09 
 
Doing 
something 
to help 
yourself 
Getting rid of 
it 
 
 
 
 
 
 
 
 
 
Monitoring 
 
 
 
 
 
 
 
 
 
 
Reducing 
anxiety 
 
 
 
 
 
 
 
 
 
 
 
Having surgery 
 
Having 
chemotherapy or 
radiotherapy 
 
Trying alternative 
treatments 
 
 
 
Attending follow 
up visits 
 
 
Self-examination 
 
Compliance with 
follow up 
 
 
 
Other things are 
worse 
 
 
 
 
The melanoma 
could be worse 
 
 
 
 
 
ÒEvery surgery on its own is painful, 
obviously at the beginning. But the idea 
of, you know, that every surgery is 
making you better. That helps a lot.Ó  
Participant 05 
 
 Ò…when I was going through the 
treatment I looked in to some diets … 
and I looked at an alternative treatment 
with cancerÓ. Participant 08 
 
Ò…soon as everybody said youÕre alright 
for the time being, thatÕs gone out of my 
mind then.Ó Participant 04. 
 
ÒI come to [the hospital] every 3 months, 
but they do no more than, than what I do 
every day.Ó 
 
Ò I check in the shower every morningÓ 
Participant 06 
 
ÒMy husband had major surgery and 
theyÕve left him with a numb left leg and 
he gets a lot off pins and needles. But I 
didnÕt think mine was as severe as his.Ó 
Participant 01 
 
ÒWell there are so many people that are 
dying from melanoma that I consider 
myself very lucky.Ó 
 
 
ÒI think because weÕve been through it 
with my Mum, itÕs like I say, weÕve been 
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Sun 
avoidance 
 
 
 
 
Avoiding sun 
exposure 
Using sun 
protection 
Perceived risk 
from sun 
exposure 
 
a little bit desensitised towards cancer 
and you just sort of take it as it comes.Ó 
Participant 02 
 
ÒIÕll put some factor 50 and 60 on you 
know …. Even winter like, you know if 
itÕs a clear day having to put sun lotion 
on in November and things like that you 
know.Ó 
 
Sharing the 
burden of 
worry  
Choosing to 
share the 
worry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Choosing not 
to share the 
burden of 
worry 
 
Someone who 
has room for my 
problems 
 
Someone who 
knows me 
 
 
Someone 
separate from the 
hospital or family  
 
Strengthening 
relationships 
 
Exchanging 
experiences 
 
Gaining 
reassurance 
 
Not bothering 
people 
 
Not adding to the 
burden of family 
ÒI ask them anyway but sometimes you 
feel more comfortable asking somebody 
who youÕve seen on a regular basis like, 
you speak on a one to one. You get a bit 
more personal with them like donÕt you. 
They know you, your lifestyle.Ó 
Participant 04 
  
ÒI spoke to one of my best friends. SheÕs 
Godmother to my children, I spoke to her 
about it. I suppose more when I didnÕt 
want to worry my husband about things, 
sheÕs the other person that I could sound 
off to…Ó Participant 10 
 
 
 
 
 
 
 
ÒYou see how busy people are and 
thatÕs a put off. TheyÕre rushing up and 
down and doing this and doing that. I 
think I donÕt want to bother her.Ó 
Participant 07 
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